Linear reverse risk of HDL-C levels for predicting cardiovascular disease: it is not that straightforward!
Eur J Prev Cardiol
.
2022 Nov 8;29(15):2055-2057.
doi: 10.1093/eurjpc/zwaa032.
Authors
Ragavendra R Baliga
1
,
Eric H Yang
2
,
Eduardo Bossone
3
Affiliations
1
Division of Cardiovascular Medicine, The Ohio State Wexner Medical Center, Columbus, OH, USA.
2
Division of Cardiology, Department of Medicine, CLA Medical Center, University of California at Los Angeles, Los Angeles, CA, USA.
3
Division of Cardiology, Internal Medicine Department, A. Cardarelli Hospital, Via Cardarelli 9, Naples - 80131, Italy.
PMID:
33624024
DOI:
10.1093/eurjpc/zwaa032
No abstract available
MeSH terms
Cardiovascular Diseases* / diagnosis
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / prevention & control
Cholesterol, HDL
Humans
Risk Factors
Substances
Cholesterol, HDL